Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.

T S Kim, R H DeKruyff, R Rupper, H T Maecker, S Levy and D T Umetsu
J Immunol May 1, 1997, 158 (9) 4137-4144;
T S Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R H DeKruyff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Rupper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H T Maecker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Levy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D T Umetsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 158 no. 9 4137-4144
PubMed 
9126973

Published By 
The American Association of Immunologists, Inc.
Print ISSN 
0022-1767
Online ISSN 
1550-6606
History 
  • Published online May 1, 1997.

Copyright & Usage 
Copyright © 1997 by American Association of Immunologists

Author Information

  1. T S Kim,
  2. R H DeKruyff,
  3. R Rupper,
  4. H T Maecker,
  5. S Levy and
  6. D T Umetsu
  1. Department of Pediatrics, Stanford University, CA 94305, USA.

Article usage

Article usage: September 2000 to March 2021

AbstractFullPdf
Sep 2000100
Nov 2000100
Dec 2000200
Total 2000400
Jan 2001100
Feb 2001200
Mar 2001200
Apr 2001700
May 2001400
Jun 2001300
Jul 2001200
Aug 2001300
Sep 2001200
Oct 2001500
Nov 2001004
Dec 20014024
Total 200135028
Jan 20021048
Feb 2002204
Mar 2002008
Apr 2002109
May 2002107
Jun 2002102
Jul 20022013
Aug 2002003
Sep 2002002
Oct 2002005
Nov 2002203
Dec 2002102
Total 2002110106
Jan 2003005
Feb 2003001
Mar 2003004
Apr 2003102
May 2003002
Jun 2003301
Jul 2003305
Aug 2003400
Sep 2003501
Oct 2003401
Nov 2003704
Dec 2003104
Total 200328030
Jan 2004308
Feb 2004808
Mar 2004501
Apr 2004706
May 20041601
Jun 20041408
Jul 2004709
Aug 20041109
Sep 20041603
Oct 2004202
Nov 200411010
Dec 2004503
Total 2004105068
Jan 2005607
Feb 2005801
Mar 2005606
Apr 2005101
May 2005205
Jun 20053012
Jul 2005405
Aug 2005404
Sep 2005702
Oct 2005201
Nov 20051007
Dec 2005309
Total 200556060
Jan 2006509
Feb 2006406
Mar 2006507
Apr 2006002
May 2006200
Jun 2006205
Jul 2006203
Aug 2006107
Sep 2006207
Oct 2006205
Nov 2006004
Dec 2006004
Total 200625059
Jan 2007409
Feb 2007409
Mar 2007601
Apr 2007202
May 2007004
Jun 20073010
Jul 2007001
Sep 2007204
Oct 2007106
Nov 2007402
Dec 2007203
Total 200728051
Jan 2008109
Feb 2008307
Mar 2008404
Apr 2008004
May 2008506
Jun 2008604
Jul 2008302
Aug 20081108
Sep 2008706
Oct 20087011
Nov 2008802
Dec 2008508
Total 200860071
Jan 2009804
Feb 2009507
Mar 2009402
Apr 2009302
May 2009305
Jun 2009907
Jul 2009805
Aug 2009701
Sep 2009905
Oct 2009604
Nov 2009904
Dec 20091204
Total 200983050
Jan 2010404
Feb 2010901
Mar 2010902
Apr 2010609
May 2010708
Jun 2010603
Jul 20101003
Aug 2010305
Sep 20105010
Oct 201012012
Nov 2010701
Dec 20101107
Total 201089065
Jan 20111201
Feb 2011801
Mar 20111105
Apr 2011909
May 2011704
Jun 20111408
Jul 2011509
Aug 20111402
Sep 2011301
Oct 20111104
Nov 2011701
Dec 20111107
Total 2011112052
Jan 20121602
Feb 2012803
Mar 20121507
Apr 2012505
May 20121105
Jun 20121409
Jul 20121504
Aug 2012702
Sep 20121101
Oct 20121105
Nov 20121108
Dec 20121402
Total 2012138053
Jan 20131004
Feb 20131307
Mar 20131001
Apr 20131005
May 2013401
Jun 2013706
Jul 2013101
Aug 20131004
Sep 2013901
Oct 2013800
Nov 2013605
Dec 2013903
Total 201397038
Jan 2014202
Feb 2014201
Mar 2014201
Apr 20141002
May 20141203
Jun 2014304
Jul 2014804
Aug 2014401
Sep 20141007
Oct 2014201
Nov 2014504
Dec 2014503
Total 201465033
Jan 20151201
Feb 2015105
Mar 20153003
Apr 2015302
May 2015305
Jun 20151905
Jul 2015501
Aug 2015905
Sep 20151011
Oct 20154010
Nov 20151603
Dec 2015503
Total 2015117144
Jan 2016104
Feb 20161402
Mar 2016700
Apr 2016402
May 2016801
Jun 2016301
Jul 2016403
Aug 2016805
Sep 2016100
Oct 2016507
Nov 2016202
Dec 2016601
Total 201663028
Jan 20171800
Feb 20172506
Mar 2017903
Apr 20171603
May 20171204
Jun 2017804
Jul 2017600
Aug 20171302
Sep 2017400
Oct 20171203
Nov 2017900
Dec 20171207
Total 2017144032
Jan 20181504
Feb 2018800
Mar 20181402
Apr 20181601
May 20183005
Jun 2018603
Jul 20182103
Aug 2018300
Sep 20181403
Oct 20185307
Nov 20181401
Dec 2018300
Total 2018197029
Jan 20191604
Feb 2019100
Mar 2019302
Apr 2019301
May 20191001
Jun 2019400
Jul 20191908
Aug 20191002
Sep 20192200
Oct 2019703
Nov 20191702
Dec 2019300
Total 2019115023
Jan 20201802
Feb 2020900
Mar 20202100
Apr 20201000
May 2020701
Jun 20201002
Jul 2020802
Aug 20201102
Sep 20201100
Oct 20201800
Nov 20201000
Dec 20201602
Total 2020149011
Jan 20212202
Feb 2021602
Mar 2021501
Total 20213305
Total17541936

PreviousNext
Back to top

In this issue

The Journal of Immunology
Vol. 158, Issue 9
1 May 1997
  • Table of Contents
  • Table of Contents (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
T S Kim, R H DeKruyff, R Rupper, H T Maecker, S Levy, D T Umetsu
The Journal of Immunology May 1, 1997, 158 (9) 4137-4144;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
T S Kim, R H DeKruyff, R Rupper, H T Maecker, S Levy, D T Umetsu
The Journal of Immunology May 1, 1997, 158 (9) 4137-4144;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606